Accelrys Unveils Industry-First, Enterprise-Wide Cheminformatics Suite
October 10, 2011
ATHENS, Greece--Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the new Accelrys Cheminformatics Suite, providing R&D organizations with the most robust, end-to-end solution available to register, search, mine and analyze information on chemical structures and reactions, chemically modified sequences and associated data such as inventory, assay and analytical results. Industry-leading [...]
Accelrys Adds HEOS® by SCYNEXIS to New Cheminformatics Suite
October 10, 2011
ATHENS, Greece--Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced its agreement with SCYNEXIS, Inc., to market and sell the SCYNEXIS Hit Explorer Operating System (HEOS) for comprehensive drug discovery information management. This reseller agreement is the next phase of the ongoing partnership between Accelrys and SCYNEXIS that is enabling a [...]
8th Confocal Raman Imaging Symposium, Ulm, Germany
October 10, 2011
With a record-breaking 95 delegates, the 8th Confocal Raman Imaging Symposium took place in Ulm, Germany from October 5th – 6th. Over the years the symposium has evolved to become one of the leading venues worldwide for the discussion of the latest developments in high-resolution Raman Imaging. Featuring a global line-up of Raman Imaging experts, [...]
Exiqon launches new products for the research and development of LNA™ based drugs
October 10, 2011
Exiqon A/S, a leading supplier of high-value products for gene expression analysis, today announced the expansion of its product offering to include LNA™ products for the research and development of RNA targeted medicine including LNA™ as the active pharmaceutical ingredient. The first new products being offered include the following: oxy-LNA™ amidites in kilogram quantities LNA™ [...]
October 10, 2011
PHILADELPHIA - Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new informatics solution specifically developed for laboratory professionals working in water and environmental testing laboratories. The Thermo Scientific Water and Environmental LIMS is preconfigured to enable customers to comply with water and environmental regulatory guidelines and requirements, and it is [...]
October 9, 2011
REYKJAVIK, Iceland - Scientists at deCODE Genetics and academic collaborators from Iceland, Norway, Denmark, the Netherlands and the USA today report the discovery of low frequency variants in the human genome that associate with risk of gout, a common inflammatory arthritis, and serum uric acid levels. The study was done in collaboration with Illumina, Inc., [...]
Paladin Capital Group Marks Another Successful Exit in Sale of QuantaLife
October 8, 2011
Washington DC – QuantaLife, one of the nation’s most promising life sciences companies, was purchased this week by Bio-Rad Laboratories for $162 million – marking another successful exit for Paladin Capital Group. Paladin helped nurture QuantaLife from a tiny startup with a great idea to a dynamic company that is helping to accelerate the search [...]
SPD Chairman Dr. Frank-Walter Steinmeier visits BINDER GmbH
October 7, 2011
A personal meeting in Berlin was the initial impetus, then SPD Chairman Dr. Frank-Walter Steinmeier accepted the invitation from Peter M. Binder, Managing Partner of BINDER GmbH, to visit the company in the Gänsäcker business park in Tuttlingen, Germany. Peter M. Binder greeted his guest at the Research & Development Center. Dr. Frank-Walter Steinmeier allowed [...]
Fluidigm Affirms 2011 Financial Outlook
October 7, 2011
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced it is affirming its previously disclosed 2011 financial outlook. In its August 9, 2011 earnings release, Fluidigm disclosed that for the full year 2011, year-over-year product revenue growth was projected to be at the high end of a range of 27% to 30% and revenue [...]
Exiqon A/S completes litigation against Santaris Pharma a/s
October 7, 2011
Exiqon A/S today announced that the company has completed its litigation against Santaris Pharma a/s. In 2010, Exiqon initiated arbitration proceedings to defend its business against Santaris Pharma. Exiqon’s product offering includes LNA™ amidites and LNA™ oligonucleotides for the research and development of pharmaceutical products. Exiqon has the exclusive right to supply such products except [...]
